Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
SLC27A2 is a membrane-associated fatty acid transport protein, FATP2, encoded by the SLC27A2 gene. Its precise membrane topology should not be inferred as a multi-pass transport pore; FATP2 localizes to plasma membrane as well as intracellular membrane associated compartments including microsomal and peroxisomal membranes. SLC27A2 belongs to a family of fatty acid transport proteins that participate in the handling of long chain fatty acids. The protein contributes to cellular fatty acid uptake and has ATP- and CoA-dependent acyl-CoA synthetase activity, activating long-chain and very-long-chain fatty acids to their CoA esters. These uptake-associated effects do not by themselves establish an independent transmembrane channel mechanism. SLC27A2 is expressed in several tissues, with relatively prominent abundance in hepatic and renal regions. Membrane association and catalytic-domain organization influence substrate access in the relevant cellular compartment. Proper folding and membrane insertion are prerequisites for efficient substrate handling. Posttranslational modifications applied to SLC27A2 itself could tune its molecular availability within cellular space, and may adjust the extent of substrate processing. Distinct cellular contexts tend to shape the overall pool of functional SLC27A2 molecules, as surrounding molecular environment can influence substrate access toward candidate fatty acid molecules. Variation of polypeptide abundance does not always correspond to equivalent transport output, since intrinsic membrane topology can place additional constraints on protein function.
SLC27A2 mediated fatty acid handling modifies substrate molecular status and might contribute to downstream metabolic pathway engagement, which could reshape cellular lipid handling profiles. Variation in SLC27A2 expression level alters the total pool of accessible transport proteins within cellular environments. Residue alteration within catalytic regions can impair acyl CoA synthesis capability. Sequence variation within transmembrane segments could disturb membrane insertion behaviours without abolishing full length polypeptide folding. Shifts in intracellular SLC27A2 abundance may reshape the range of available fatty acid substrates and modulate downstream molecular events linked to lipid metabolism. Different fatty acid species may display uneven sensitivity toward SLC27A2 mediated processing, which is proposed to generate graded biological responses inside cellular systems. Altered protein activity might indirectly reshape the composition of intracellular metabolic complexes by changing substrate processing status of selected molecules. Such indirect effects do not rely on stable physical interaction between SLC27A2 and every downstream effector molecule, and can expand the scope of molecular events influenced by this protein within complex cellular contexts.
Fig. 1 Conceptual FATP-family model showing membrane association, conserved functional regions and fatty-acid activation pathways. This is not an experimentally resolved human SLC27A2 membrane topology or evidence for a multi-pass transport pore. FATP2-associated uptake should be distinguished from ATP- and CoA-dependent acyl-CoA synthesis.1
The functions of SLC27A2/FATP2 include fatty-acid uptake-associated processes and ATP- and CoA-dependent fatty-acid activation:
Creative Biolabs offers purified SLC27A2 protein samples via standardized preparation workflows, including full length SLC27A2 constructs and isolated individual domain variants. FATP2 preparations may support selected acyl-CoA synthetase studies, whereas cellular models may be used to assess fatty-acid uptake and activation. All samples receive routine quality screening. Enzyme assays require fatty-acid substrate, ATP and CoA; cellular uptake studies measure a different endpoint and do not alone demonstrate a transmembrane channel mechanism. All sample batches follow unified processing standards to support comparative laboratory analysis across separate test groups. Suitability for a specific assay depends on construct design and experimental validation.
Not finding the membrane potein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides stable SLC27A2-expressing cell lines with varied expression levels, applicable to membrane transport protein characteristic observation and substrate handling related research. Sample evaluation includes verification of sustained target expression during culture and preliminary substrate interaction associated observation, which can support comparative analysis of transport protein associated behaviours under different expression statuses. These cell systems can be matched with diverse laboratory analysis schemes to observe changes of substrate engagement efficiency under different target expression abundances.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
Antibody reagents targeting SLC27A2 are generated via mature protein preparation workflows, compatible with multiple routine laboratory detection methods for cellular localization profiling and molecular complex identification, to support systematic analysis of SLC27A2 distribution and fatty acid transport associated molecular complexes across diverse laboratory research setups. The antibody series can cooperate with other common laboratory detection reagents to complete multi dimensional observation of target distribution inside tissue samples.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for SLC27A2 research:
SLC27A2 may function as an integral membrane fatty acid transport protein and participate in fatty acid binding, acyl CoA synthesis and modulation of lipid metabolic events.
SLC27A2 expression status may influence available transport pool for fatty acid substrate handling, serving as a regulatory mediator of lipid metabolism related biological processes.
No, all SLC27A2 related products and services are strictly for research use only, not intended for clinical related operations. All material designs and functional tests are only optimized for basic laboratory research scenarios, without matching clinical application standards.
Offerings include full length SLC27A2 protein, target specific recombinant antibodies and adjustable expression cell research models, supporting fatty acid transport substrate handling research.
These reagents are suited for research focused on SLC27A2 driven molecular events, including membrane transport function, fatty acid binding and acyl CoA synthesis related mechanistic studies under laboratory research only settings.